Sharleen St.surin-lord, M.D. Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1400 Mercantile Ln, Suite 110, Largo, MD 20774 Phone: 301-773-7546 |
Laura Eastburn Keck Gifford, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Largo, MD 20774 Phone: 800-777-7904 |
Dr. Barbara Christine Williamson, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1400 Mercantile Ln, Ste#110, Largo, MD 20774 Phone: 301-772-9775 Fax: 301-772-8395 |
Dr. Ahmad Reza Hossani-madani, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 |
News Archive
Boston Scientific Corporation has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its Adapt Monorail Carotid Stent System in combination with its FilterWire EZ Embolic Protection System for treatment of carotid artery disease in patients at high risk for carotid surgery.
The U.S. Drug Enforcement Administration (DEA) had to resort to its emergency powers this Wednesday to ban K2 and other "fake pot" products that mimic the effects of marijuana. As of now it is illegal to possess or sell the five chemicals used to make the products for at least one year. The agency and the Department of Health and Human Services will further debate whether the chemicals should be permanently added to the federal list of controlled substances considered unsafe, highly abused and without medical use.
Patients with undiagnosed neurocognitive deficits are more likely to undergo joint replacement surgeries and suffer worse outcomes, finds study.
BerGenBio AS, an oncology biopharmaceutical company, is pleased to announce the award of a NOK 13 million grant from the Research Council of Norway's User-driven Research based Innovation programme (BIA) to help fund research into novel therapeutics for inhibiting tumor epithelial-mesenchymal transition (EMT), a key driver of metastasis (cancer spread) and a mechanism of drug-resistance.
Ionizing radiation, toxic chemicals, and other agents continually damage the body's DNA, threatening life and health: unrepaired DNA can lead to mutations, which in turn can lead to diseases like cancer.
› Verified 5 days ago